MURSLA LIMITED
Significant control: Pierre Michel Arsene (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Mursla Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Mursla Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
MURSLA LIMITED is an active private limited company (company number 10722951) incorporated on 12 April 2017, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£513k and cash of £117k, with 13 employees on average. Net assets fell 287% on the prior period (£274k).
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
- Pierre Michel Arsene
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Victor Manuel Serdio Villarreal
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 12 April 20179 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 26 April 2027in 183 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£513k | £117k | £402k | — | — | −£1.70m | 13 |
| 31 December 2024 | £274k | £309k | £395k | — | — | −£1.77m | 12 |
| 31 December 2023 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-512,615 at 31 December 2025
- Net assets down 25% or more on the prior period-287.4% vs prior period
- Cash at bank of £50,000 or moreCash £117,254
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 12 April 2017
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 183 days
- Accounts period endNet liabilities £513k · small accounts
- Accounts period endNet assets £274k · small accounts
- Accounts period end
- Incorporated
Similar companies in Cambridge
- RDP LIFE SCIENCES LIMITEDCambridge · inc. Apr 2017
- AIVIVO LTDCambridge · inc. Mar 2017
- NERRE THERAPEUTICS HOLDINGS LIMITEDCambridge · inc. May 2017
- ELECTRONRX LIMITEDCambridge · inc. Mar 2017
- NORTHSTAR BIOLOGY LTDCambridge · inc. Mar 2017
- SHIFT BIOSCIENCE LIMITEDCambridge · inc. May 2017
All companies incorporated on 12 April 2017 · in Apr 2017.
Reminders for MURSLA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.